REMEDY : BNSSG referral pathways & Joint Formulary

BNSSG Paediatric Joint Formulary
Home > Formulary : Paediatric > Recent Decisions > 2019 >

Decisions 3rd December 2019

Recent JFG Decisions

 

At the meeting on the 3rd December 2019 the following actions / changes to the formulary were agreed:

 

Zanamivir (intravenous) (TLS Red)

  • for treatment of severe/ complicated influenza A or B virus infection where there is suspected resistance to anti-viral treatments other than zanamivir and who are unable to take oral or inhaled medication

Budesonide orodispersible tablets (Jorveza®) (Amber 3 months)

  • Change from TLS Red to TLS Amber 3 months